期刊文献+

临床护理路径在原发性肝癌患者TACE介入术后恢复中的应用 被引量:3

下载PDF
导出
摘要 目的探讨临床护理路径在原发性肝癌(HCC)患者肝动脉化疗栓塞术(TACE)介入术后恢复中的应用效果。方法选取2019年1月至2020年1月我院收治的行TACE介入治疗的70例HCC患者作为研究对象,按照随机数表法将其分为实验组与对照组,各35例。对照组患者实行TACE介入治疗常规护理,实验组患者在此基础上进行临床护理路径干预,观察对比两组患者护理后的生活质量以及并发症发生率。结果实验组患者生活质量评分显著高于对照组,患者术后的并发症发生率显著低于对照组,差异有统计学意义(P<0.05)。结论在HCC患者TACE介入术后恢复中采用临床护理路径干预效果较好,可显著降低患者的并发症发生率,提高患者的生活质量,临床具有重要的积极意义。
出处 《结直肠肛门外科》 2021年第S02期131-131,共1页 Journal of Colorectal & Anal Surgery
  • 相关文献

参考文献2

二级参考文献16

  • 1Kazuhiro Kasai,Akira Ushio,Yukiho Kasai,Kei Sawara,Yasuhiro Miyamoto,Kanta Oikawa,Yasuhiro Takikawa,Kazuyuki Suzuki.Therapeutic efficacy of transarterial chemo-embolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma[J].World Journal of Gastroenterology,2013,19(14):2242-2248. 被引量:3
  • 2XinLi Gan-ShengFeng Chuan-ShengZheng Chen-KaiZhuo XiLiu.Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level[J].World Journal of Gastroenterology,2004,10(19):2878-2882. 被引量:54
  • 3Masami Minagawa,Masatoshi Makuuchi.Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus[J].World Journal of Gastroenterology,2006,12(47):7561-7567. 被引量:78
  • 4Masatoshi Kudo,Kazuho Imanaka,Nobuyuki Chida,Kohei Nakachi,Won-Young Tak,Tadatoshi Takayama,Jung-Hwan Yoon,Takeshi Hori,Hiromitsu Kumada,Norio Hayashi,Shuichi Kaneko,Hirohito Tsubouchi,Dong Jin Suh,Junji Furuse,Takuji Okusaka,Katsuaki Tanaka,Osamu Matsui,Michihiko Wada,Iku Yamaguchi,Toshio Ohya,Gerold Meinhardt,Kiwamu Okita.Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma[J].European Journal of Cancer.2011(14) 被引量:5
  • 5European Association for the Study of the Liver,European Organisation for Research and Treatment of Cancer.EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma[J].Journal of Hepatology.2012(4) 被引量:41
  • 6Stephen Chan,Tony Mok,Brigette Ma.Management of Hepatocellular Carcinoma: Beyond Sorafenib[J].Current Oncology Reports.2012(3) 被引量:2
  • 7Ju‐Yeon Cho,Yong‐Han Paik,Hee Chul Park,Jeong Il Yu,Won Sohn,Geum‐Youn Gwak,Moon Seok Choi,Joon Hyeok Lee,Kwang Cheol Koh,Seung Woon Paik,Byung Chul Yoo.The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma[J].Liver Int.2014(5) 被引量:5
  • 8J.M. Theysohn,J. Ertle,S. Müller,J.F. Schlaak,F. Nensa,S. Sipilae,A. Bockisch,T.C. Lauenstein.Hepatic volume changes after lobar selective internal radiation therapy (SIRT) of hepatocellular carcinoma[J].Clinical Radiology.2013 被引量:2
  • 9Toshiyuki Irie,Masashi Kuramochi,Nobuyuki Takahashi.Dense Accumulation of Lipiodol Emulsion in Hepatocellular Carcinoma Nodule during Selective Balloon-occluded Transarterial Chemoembolization: Measurement of Balloon-occluded Arterial Stump Pressure[J].CardioVascular and Interventional Radiology.2013(3) 被引量:1
  • 10Sang Min Yoon,Young-Suk Lim,Hyung Jin Won,Jong Hoon Kim,Kang Mo Kim,Han Chu Lee,Young-Hwa Chung,Yung Sang Lee,Sung Gyu Lee,Jin-hong Park,Dong Jin Suh.Radiotherapy Plus Transarterial Chemoembolization for Hepatocellular Carcinoma Invading the Portal Vein: Long-Term Patient Outcomes[J].International Journal of Radiation Oncology Biology Physics.2012(5) 被引量:1

共引文献41

同被引文献25

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部